Product category:
Nucleic acid sequencing and synthesis
News Release from: Tecan Group | Subject: Genesis RWS
Edited by the Laboratorytalk Editorial
Team on 17 May 2007
Genesis RWS workstations seek molecules
in Japan
Japan Tobacco's pharmaceutical research and discovery team turns to Tecan and Remp for automated sample management
Japan Tobacco's drug discovery team turns to Tecan and Remp for automated sample management Pharmaceutical research scientists at Japan Tobacco (JT) have two Genesis RWS workstations from Tecan, one equipped with a Remp tube punching module (TPM), for discovery of 'seed' compounds with specific or unique pharmaceutical effects on potential target molecules such as enzymes and receptors
This article was originally published on Laboratorytalk on 23 May 2002 at 8.00am (UK)
Related stories
Reduce the complexity of the proteome
Liquid fractionation device allows the rapid separation of charged molecules and particles without the use of a conventional solid polyacrylamide matrix
Twenty or thirty seed compounds are eventually selected from hundreds of thousands of compounds that are routinely investigated for potential therapeutic use in areas such as diabetes, immunology, viral diseases and bone disorders.
Akira Ohta, senior researcher at JT, explained: "The Genesis/TPM system is extremely simple to use and one person can easily control the process.
"Remp's 384 tube technology was straightforward to integrate into our workflow and the system helps to minimise the absorption of moisture during cherry picking, improving the quality of the compound solution and virtually eliminating loss of compound activity during the evaluation steps.
"It can pick as many as 700 tubes in an hour and the automated barcoding system removes the inevitable risk of human error that would be associated with handling this kind of throughput manually.".
• Tecan Group: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

